| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| Gene symbol | CD34 | Synonyms | None | Type of gene | protein-coding |
| Chromosome | 1 | Map location | 1q32.2 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | CD34 molecule | ||||
| GTO ID | GTC2280 |
| Trial ID | NCT04214886 |
| Disease | B-Cell Lymphoma | B-Cell Acute Lymphoblastic Leukemia |
| Altered gene | CD19|CD34 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19/CD34 CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Active, Not Recruiting |
| Title | CD19 Chimeric Antigen Receptor (CAR) T Cells for Adults With Recurrent or Refractory B Cell Malignancies |
| Year | 2019 |
| Country | United States |
| Company sponsor | Loyola University |
| Other ID(s) | 212594 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||||||
|
|||||||||||||